Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

11.05
Delayed Data
As of 11:32am ET
 +0.33 / +3.08%
Today’s Change
4.13
Today|||52-Week Range
12.00
-2.21%
Year-to-Date

Today’s Trading

Previous close10.72
Today’s open10.71
Day’s range10.70 - 11.05
Volume358,970
Average volume (3 months)1,675,536
Market cap$1.1B
Dividend yield--
Data as of 11:32am ET, 03/02/2015

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-27.29%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PDLIPDL BioPharma Inc+0.01+0.21%
EBSEmergent BioSolution...+0.14+0.47%
SAGESAGE Therapeutics In...+0.13+0.30%
ARRYArray Biopharma Inc+0.50+6.28%
Data as of 11:47am ET, 03/02/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Senior Vice President-
Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account